Evidence map›Paper›PMID 28780965›Full record

ReviewCellular immunology2017

Regulation of systemic autoimmunity and CD11c

Michela Manni, Edd Ricker, Alessandra B Pernis

Abstract readReview
In one paragraph

Review in Cellular immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. CD11cJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  12. Article
  13. Review
  14. Review
  15. Hypertension genomics and cardiovascular prevention.Annals of translational medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michela ManniAutoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY, USA.
Edd RickerAutoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY, USA; Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA.
Alessandra B PernisAutoimmunity and Inflammation Program, Hospital for Special Surgery, New York, NY, USA; Graduate Program in Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA; David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY, USA; Department of Medicine, Weill Cornell Medical College, Cornell University, New York, NY, USA. Electronic address: pernisa@hss.edu.

Funding

Novel signaling pathways in lupus pathogenesisR01AR064883 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI PERNIS, ALESSANDRA B · 2015 to 2019
$1.9M
Regulatory Mechanisms Controlling TFH Responses in LupusR01AR070146 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI PERNIS, ALESSANDRA B · 2016 to 2020
$1.9M
NIAMS NIH HHS R01 AR064883NIAMS NIH HHS R01 AR070146
6 · The paper itself

Abstract

Recent studies have revealed the existence of a T-bet dependent subset of B cells, which expresses unique phenotypic and functional characteristics including high levels of CD11c and CD11b. In the murine system this B cell subset has been termed Age/autoimmune-associated B cells (ABCs) since it expands with age in non-autoimmune mice and it prematurely accumulates in autoimmune-prone strains. The molecular mechanisms that promote the expansion and function of ABCs are largely unknown. This review will focus on the SWEF proteins, a small family of Rho GEFs comprised of SWAP-70 and its homolog DEF6, a newly identified risk variant for human SLE. We will first provide an overview of the SWEF proteins and then discuss the complex array of biological processes that they control and the autoimmune phenotypes that spontaneously develop in their absence, highlighting the emerging involvement of these proteins in regulating ABCs. A better understanding of the pathways controlled by the SWEF proteins could help provide new insights into the mechanisms responsible for the expansion of ABCs in autoimmunity and potentially guide the design of novel therapeutic approaches.

Indexed as

AnimalsAutoimmunityB-LymphocytesB-Lymphocyte SubsetsCD11c AntigenDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsHumansMice, KnockoutMinor Histocompatibility AntigensNuclear ProteinsT-bet Transcription FactorT-Box Domain ProteinsCD11c AntigenDef6 protein, mouseDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsMinor Histocompatibility AntigensNuclear ProteinsSwap70 protein, mouseT-bet Transcription FactorT-Box Domain ProteinsAge-associated B cellsAutoimmunityDEF6SWAP-70

Identifiers

PMID28780965
PMCPMC5877469

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.